A carregar...
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
BACKGROUND: Tumour necrosis factor (TNF)‐alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) for reducing the risk of joint damage, improving physical function and improving the quality of life. This review is an update of the 2014 Cochrane Review of the treatment of RA wi...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483724/ https://ncbi.nlm.nih.gov/pubmed/28884785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007649.pub4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|